Sublingual Immunotherapy: Other Indications

Immunology and Allergy Clinics of North America

Volumn 31, Issue 2, 2011, Pages 279-287

  Passalacqua, Giovanni ^a   Compalati, Enrico ^a   Canonica, Giorgio Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Atopic dermatitis; Food allergy; Hymenoptera venom; Latex allergy; Sublingual immunotherapy

Indexed keywords

BEE VENOM; HOUSE DUST ALLERGEN; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IMMUNOMODULATING AGENT; INTERLEUKIN 4; INTERLEUKIN 5; LATEX; PEANUT EXTRACT; PLACEBO;

ALLERGIC DISEASE; ALLERGY; ATOPIC DERMATITIS; BEE STING; CYTOKINE PRODUCTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FOOD ALLERGY; HAZELNUT; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; PEANUT ALLERGY; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVIEW; SUBLINGUAL IMMUNOTHERAPY; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY;

EID: 79955433984     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2011.02.011     Document Type: Review

References (57)

1. Passalacqua G., Canonica G.W. Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol 2006, 6:449-454.
2. Bousquet J., Lockey R., Malling H.J., et al. Allergen immunotherapy: therapeutical vaccines for allergic diseases. World Health Organization position paper. Allergy 1998, 53(Suppl 43):1-33.
3. Bousquet J., Van Cauwenberge P. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108(Suppl 5):S146-S150.
4. Canonica G.W. WAO Position Paper on Sublingual immunotherapy. Allergy 2009, 66(Suppl 82):1-15.
5. Wilson D.R., Torres L., Durham S.R. Sublingual immunotherapy for allergic rhinitis. Allergy 2005, 60:3-8.
6. Compalati E., Passalacqua G., Bonini M., et al. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009, 64(11):1570-1579.
7. Di Bona D., Plaia A., Scafidi V., et al. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis. J Allergy Clin Immunol 2010, 126(3):558-566.
8. Penagos M., Compalati E., Tarantini F., et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in children. Meta analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2006, 97:141-148.
9. Calamita Z., Saconato H., Bronhara Pelà A., et al. Efficacy of sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 2006, 61:1162-1172.
10. Penagos M., Passalacqua G., Compalati E., et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008, 133:599-609.
11. Cox L.S., Linnemann D.L., Nolte H., et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006, 117:1021-1035.
12. Agostinis F., Tellarini L., Falagiani P., et al. Safety of SLIT in very young children. Allergy 2005, 60:133.
13. Fiocchi A., Pajno G., La Grutta S., et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005, 95:254-258.
14. Di Rienzo V., Minelli M., Musarra A., et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005, 35:560-564.
15. Stelmach I., Kaczmarek-Woźniak J., Majak P., et al. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009, 39:401-408.
16. Mortemousque B., Bertel F., De Casamayor J., et al. House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2003, 33:464-469.
17. Cosmi L., Santarlasci V., Angeli R., et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 2006, 36:261-272.
18. Ciprandi G., Fenoglio D., Cirillo I., et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005, 95:38-44.
19. Bohle B., Kinaciyan T., Gerstmayr M., et al. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007, 120:707-713.
20. Ippoliti F., De Sanctis W., Volterrani A., et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003, 14:216-221.
21. Savolainen J., Jacobsen L., Valovirta E. Sublingual immunotherapy in children modulates allergen induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006, 61:1184-1190.
22. Scadding G.W., Shamji M.H., Jacobson M.R., et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 2010, 40:598-606.
23. Oppenheimer J.J., Nelson H.S., Bock S.A., et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992, 90:256-262.
24. Nelson H.S., Lahr J., Rule R., et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997, 99:744-751.
25. Enrique E., Pineda F., Malek T., et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005, 116:1073-1079.
26. Fernández-Rivas M., Garrido Fernández S., Nadal J.A., et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009, 64:876-883.
27. Jones S.M., Pons L., Roberts J.L., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124:292-300.
28. Varshney P., Steele P.H., Vickery B.P., et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009, 124(6):1351-1352.
29. Blumchen K., Ulbricht H., Staden U., et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010, 126:83-91.
30. Severino M., Cortellini G., Bonadonna P., et al. Sublingual immunotherapy for large local reactions due to honeybee sting. Double blind placebo controlled trial. J Allergy Clin Immunol 2008, 122:44-48.
31. Golden D.B., Kelly D., Hamilton R.G., et al. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 2009, 123:1371-1375.
32. Ruëff F., Bilò M.B., Jutel M., et al. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2009, 123:272-273.
33. Severino M., Bonadonna P., Passalacqua G. Large local reactions from stinging insects: from epidemiology to management. Curr Opin Allergy Clin Immunol 2009, 9:334-337.
34. Leynadier F., Herman D., Vervloet D., et al. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 2000, 106:585-590.
35. Sastre J., Fernández-Nieto M., Rico P., et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2003, 111:985-994.
36. Tabar A.I., Anda M., Bonifazi F., et al. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients. Int Arch Allergy Immunol 2006, 141:369-376.
37. Patriarca G., Nucera E., Pollastrini E., et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg 2002, 95:956-960.
38. Cisteró Bahima A., Sastre J., Enrique E., et al. Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract. J Investig Allergol Clin Immunol 2004, 14:17-25.
39. Nettis E., Colanardi M.C., Soccio A.L., et al. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol 2007, 156:674-681.
40. Bernardini R., Campodonico P., Burastero S., et al. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study. Curr Med Res Opin 2006, 22:1515-1522.
41. Nettis E., Di Leo E., Calogiuri G., et al. The safety of a novel sublingual rush induction phase for latex desensitization. Curr Med Res Opin 2010, 26:1855-1859.
42. Antico A., Pagani M., Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 2006, 61:1236.
43. Bernardini R., Pecora S., Milani M., et al. Natural rubber latex allergy in children: clinical and immunological effects of 3-years sublingual immunotherapy. Eur Ann Allergy Clin Immunol 2008, 40:142-145.
44. Boguniewicz M., Leung D.Y. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010, 125:4-13.
45. Flohr C. How atopic is atopic dermatitis?. J Allergy Clin Immunol 2004, 114:150-158.
46. Glover M.T., Atherton D.J. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992, 22:440-446.
47. Bussmann C., Bockenhoff A., Henke H., et al. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?. J Allergy Clin Immunol 2006, 118:1292-1298.
48. Novak N. Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol 2007, 7:542-546.
49. Werfel T., Breuer K., Ruéff F., et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006, 61(2):202-205.
50. Bussmann C., Maintz L., Hart J., et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy 2007, 37:1277-1285.
51. Cadario G., Galluccio A.G., Pezza M., et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin 2007, 23:2503-2506.
52. Mastrandrea F., Serio G., Minelli M., et al. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr) 2000, 28:54-62.
53. Pajno G.B., Caminiti L., Vita D., et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007, 120:164-170.
54. Passalacqua G., Pawankar R., Baena-Cagnani C.E., et al. Sublingual immunotherapy: where do we stand? Present and future. Curr Opin Allergy Clin Immunol 2009, 9:1-3.
55. Incorvaia C., Mauro M., Cappelletti T., et al. New applications for sublingual immunotherapy in allergy. Recent Pat Inflamm Allergy Drug Discov 2009, 3:113-117.
56. Thyagarajan A., Varshney P., Jones S.M., et al. Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol 2010, 126(1):31-32.
57. Nowak-Wegrzyn A., Sicherer S.H. Immunotherapy for food and latex allergy. Clin Allergy Immunol 2008, 21:429-446.